Dr. Eng. Oliwia Zakerska-Banaszak became an employee of the Institute at the beginning of 2015. In the same year, she defended her doctoral thesis with honors entitled “Highly efficient DNA sequencing – a new diagnostic platform for testing patients’ susceptibility to anesthetic agents” and was promoted to the position of assistant professor. She gained experience during domestic and foreign scientific internships, including: at the Institute of Human Genetics in Leipzig, at the Cancer Research Institute in Vienna and at the Max Delbrueck Center in Berlin. She was a scholarship holder of the International Doctoral Projects program at the NanoBioMedical Center at the Faculty of Physics of the University of Adam Mickiewicz in Poznań. As an employee of the Nucleic Acid Function Team, he is currently conducting research on the composition and role of microbiota in the development and course of inflammatory bowel diseases, as well as other inflammatory diseases. Dr. Zakerska-Banaszak is a laboratory diagnostician, member of the National Chamber of Laboratory Diagnostics and the College of Laboratory Medicine in Poland.
dr n. roln. Oliwia Zakerska-Banaszak
Publications
The role of host genetics and intestinal microbiota and metabolome as a new insight into IBD pathogenesis.
Zakerska-Banaszak O, Zuraszek-Szymanska J, Eder P, Ładziak K, Słomski R, Skrzypczak-Zielińska M
Int J Mol Sci, (MDPI), 2024 Sep 4; 25 (17):9589, 21 stron, doi: 10.3390/ijms25179589IF-4.9 MNiSW-140
Gut microbiota signatures in inflammatory bowel disease.
Vestergaard MV, Allin KH, Eriksen C, Zakerska-Banaszak O, Arasaradnam RP, Alam MT, Kristiansen K, Brix S, Jess T
United European Gastroenterol J, 2024, 12: 22-33.IF-5.8 MNiSW-100
Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn's disease patients.
Lykowska-Szuber L, Walczak M, Stawczyk-Eder K, Krela-Kazmierczak I, Eder P, Zakerska-Banaszak O, Dobrowolska A, Skrzypczak-Zielinska M
J Appl Genet, 2023 Dec, 64 (4): 759-88, doi: 10.1007/s13353-023-00783-7, Epub Sep 2IF-2.4 MNiSW-140
Alterations in Gut Microbiota Composition in Patients with Covid-19: A pilot Study of whole Hypervariable 16S rRNA Gene Sequencing.
Mańkowska-Wierzbicka D, Żuraszek J, Wierzbicka A, Gabryel M, Mahadea D, Baturo A, Zakerska-Banaszak O, Słomski R, Skrzypczak-Zielińska M, Dobrowolska A
Biomedicines (MDPI), 2023, Jan 27; 11 (2): 367, 16 str; doi: 10.3390/biomedicines11020367IF-4.7 MNiSW-100
Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota—A Narrative Review.
Krela-Kaźmierczak I, Zakerska-Banaszak O, Skrzypczak-Zielińska M, Łykowska-Szuber L, Szymczak-Tomczak A, Zawada A, Rychter AM, Ratajczak AE, Skoracka K, Skrzypczak D, Marcinkowska E, Słomski R, Dobrowolska A
Nutrients (MDPI), 2022, 14 (12), 252, 28 str, doi/10.3390/nu14122520IF-5,719 MNiSW-140
Cytotoxicity of thiopurine drugs in patients with inflammatory bowel disease.
Zakerska-Banaszak O, Łykowska-Szuber L, Walczak M, Żuraszek J, Zielińska A, Skrzypczak-Zielińska M
Toxic, 2022, 10 (4), 151, 19 stron, doi/10.3390/toxics1004015IF-4,146 MNiSW-70
Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study.
Zakerska-Banaszak O, Tomczak H, Gabryel M, Baturo A, Wolko L, Michalak M, Malinska N, Mankowska-Wierzbicka D, Eder P, Dobrowolska A, Słomski R, Skrzypczak-Zielińska M
Scientific Rep, 2021 Jan 25, 11, art No 2166,.13 str., https://doi.org/10.1038/s41598-021-81628-3IF-3,998 MNiSW-140
Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?
Walczak M, Łykowska-Szuber M, Plucińska M, Stawczyk-Eder K, Zakerska-Banaszak O, Eder P, Krela-Kaźmierczak I, Michalak M, Żywicki M, Karłowski WM, Szalata M, Dobrowolska A, Słomski R, Skrzypczak-Zielińska M
Front. Pharmacol., 2020 Aug 14, 11, art 1207,12 str| ,https://doi.org/10.3389/fphar.2020.01207IF-4,225 MNiSW-100
The Effectiveness of Multi-Session FMT Treatment in Active Ulcerative Colitis Patients: A Pilot Study
Mańkowska-Wierzbicka D, Stelmach-Mardas M, Gabryel M, Tomczak H, Skrzypczak-Zielińska M, Zakerska-Banaszak O, Sowińska A, Mahadea D, Baturo A, Wolko Ł, Słomski R, Dobrowolska A
Biomedicines, 2020 Aug 3;8 (8):E268. doi: 10.3390/biomedicines8080268IF-4,717 MNiSW-20
Analysis of the tumor necrosi factor superfamily member 11 gene polymorphism with bone mineral density and bone fracture frequency in patients with postmenopausal osteoporosis.
Wawrzyniak A, Skrzypczak-Zielińska M, Krela-Kaźmierczak I, Michalak M, Marszałek D, Marcinkowska M, Zakerska-Banaszak O, Słomski R
Adv Med Sci, 2020, 65 (2): 291-297. doi: 10.1016/j.advms.2020.05.001IF-2,570 MNiSW-100
All publications
Awards
dr n. roln. Oliwia Zakerska-Banaszak
dr hab. n. med. i n. o zdr. Marzena Skrzypczak-Zielińska
prof. dr hab. n. med. Ryszard Słomski
Biocodex award
Award in the competition 'Microbiota in health and disease' for funding a research project entitled "Treatment of patients with irritable bowel syndrome (IBS) by means of intestinal microbiota transplantation - evaluation of the therapy and its effect on the change of the intestinal microbiome". Manager dr Marcin Gabryel.
Scholarship
“Scholarship support for PH.D. students specializing in majors strategic for Wielkopolska’s development”, Sub-measure 8.2.2 Human Capital Operational Programme, co-financed by European Union under the European Social Fund; 2013.
